P. Wiczling

发表

Analyzing chromatographic data using multilevel modeling

P. Wiczling, 2018, Analytical and Bioanalytical Chemistry.

Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects

R. Kaliszan, M. Stukan, M. Markuszewski, 2019, PloS one.

Determination of pKa by pH gradient reversed-phase HPLC.

R. Kaliszan, M. Markuszewski, P. Wiczling, 2004, Analytical chemistry.

ESICM LIVES 2016: part one

Hester F. Lingsma, A. M. Cavalheiro, H. S. King, 2016, Intensive Care Medicine Experimental.

The pharmacokinetics of midazolam and 1-OH-midazolam during oral premedication in paediatric patients

P. Wiczling, D. Januszkiewicz-Lewandowska, A. Bienert, 2016 .

Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia

K. Neville, W. Jusko, C. Thornburg, 2016, Journal of clinical pharmacology.

Combined pH/organic solvent gradient HPLC in analysis of forensic material.

R. Kaliszan, M. Markuszewski, P. Wiczling, 2005, Journal of pharmaceutical and biomedical analysis.

Maximum A Posteriori Bayesian Estimation of Chromatographic Parameters by Limited Number of Experiments.

R. Kaliszan, P. Wiczling, Łukasz Kubik, 2015, Analytical chemistry.

Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes

W. Jusko, C. Mathieu, G. Hale, 2010, Journal of clinical pharmacology.

Theoretical opportunities and actual limitations of pH gradient HPLC

R. Kaliszan, P. Wiczling, 2005, Analytical and bioanalytical chemistry.

The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients. A Bayesian approach with informative priors

R. Kaliszan, D. Siluk, P. Wiczling, 2016, Journal of Pharmacokinetics and Pharmacodynamics.

How to model temporal changes in nontargeted metabolomics study? A Bayesian multilevel perspective.

R. Kaliszan, M. Markuszewski, P. Wiczling, 2017, Journal of separation science.

Ionization of tocopherols and tocotrienols in atmospheric pressure chemical ionization.

M. Markuszewski, D. Siluk, P. Wiczling, 2018, Rapid communications in mass spectrometry : RCM.

pH gradient high-performance liquid chromatography: theory and applications.

R. Kaliszan, M. Markuszewski, P. Wiczling, 2004, Journal of chromatography. A.

Toward the General Mechanistic Model of Liquid Chromatographic Retention

W. Struck-Lewicka, M. Markuszewski, P. Wiczling, 2022, Analytical chemistry.

Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats

Aman P. Singh, P. Wiczling, L. M. Nguyen, 2018, Front. Pharmacol..

Population analysis to assess the influence of age and body weight on pharmacokinetics and pharmacodynamics of dexmedetomidine in New Zealand White rabbits.

P. Wiczling, H. Billert, J. Matysiak, 2020, Biopharmaceutics & drug disposition.

Maturation, pharmacogenomics and metabolomics as factors determining pharmacokinetic and pharmacodynamics profile of alpha‑agonist in pediatric intensive care unit patients

P. Wiczling, Z. Kokot, J. Matysiak, 2016 .

Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children

R. Kaliszan, P. Wiczling, C. Żaba, 2013, Pharmacological reports : PR.

Evaluation of robustness in untargeted metabolomics: application of multivariate analysis, linear regression and hierarchical modeling

M. Markuszewski, P. Wiczling, M. Kordalewska, 2022, Journal of Chromatography Open.

Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients

P. Wiczling, M. Nowicka, J. Matysiak, 2020, Journal of clinical pharmacology.

HPLC-MS/MS method for dexmedetomidine quantification with Design of Experiments approach: application to pediatric pharmacokinetic study.

R. Kaliszan, R. Buják, W. Struck-Lewicka, 2017, Bioanalysis.

Gradient reversed-phase high-performance chromatography of ionogenic analytes

R. Kaliszan, P. Wiczling, 2011 .

Multilevel pharmacokinetics-driven modeling of metabolomics data

R. Kaliszan, M. Markuszewski, P. Wiczling, 2017, Metabolomics.

Nonstationary Pharmacokinetics of Caspofungin in ICU Patients

G. Raszewski, P. Wiczling, D. Onichimowski, 2020, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock

G. Raszewski, P. Wiczling, D. Onichimowski, 2018, Antimicrobial Agents and Chemotherapy.

Flip‐Flop Phenomenon in Epidural Sufentanil Pharmacokinetics: A Population Study in Children and Infants

P. Wiczling, A. Bienert, A. Bartkowska-Śniatkowska, 2017, Journal of clinical pharmacology.

Overview of experimental and computational methods for the determination of the pKa values of 5-fluorouracil, cyclophosphamide, ifosfamide, imatinib and methotrexate

P. Wiczling, Celina Sikorska, Z. Kaczyński, 2017 .

pH/organic solvent double-gradient reversed-phase HPLC.

R. Kaliszan, M. Markuszewski, P. Wiczling, 2005, Analytical chemistry.

pH gradient reversed-phase HPLC.

R. Kaliszan, M. Markuszewski, P. Wiczling, 2004, Analytical chemistry.

Simultaneous determination of hydrophobicity and dissociation constant for a large set of compounds by gradient reverse phase high performance liquid chromatography-mass spectrometry technique.

R. Kaliszan, W. Struck-Lewicka, P. Wiczling, 2015, Journal of chromatography. A.

Ultra-high performance liquid chromatographic determination of levofloxacin in human plasma and prostate tissue with use of experimental design optimization procedures.

R. Kaliszan, M. Matuszewski, M. Markuszewski, 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The application of gradient reversed-phase high-performance liquid chromatography to the pK(a) and log k(w) determination of polyprotic analytes.

R. Kaliszan, M. Markuszewski, P. Wiczling, 2008, Journal of chromatography. A.

Development and validation of UHPLC method for the determination of cyclosporine A in biological samples.

R. Kaliszan, W. Struck-Lewicka, M. Markuszewski, 2014, Biomedical chromatography : BMC.

The simultaneous determination of hydrophobicity and dissociation constant by liquid chromatography-mass spectrometry.

R. Kaliszan, W. Struck-Lewicka, M. Markuszewski, 2014, Journal of pharmaceutical and biomedical analysis.

Least absolute shrinkage and selection operator and dimensionality reduction techniques in quantitative structure retention relationship modeling of retention in hydrophilic interaction liquid chromatography.

R. Kaliszan, M. Markuszewski, S. Bocian, 2015, Journal of chromatography. A.

Prediction of peptide retention at different HPLC conditions from multiple linear regression models.

Yvan Vander Heyden, Paweł Wiczling, Roman Kaliszan, 2005, Journal of proteome research.

Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery

R. Kaliszan, P. Wiczling, K. Przybyłowski, 2015, Journal of Pharmacokinetics and Pharmacodynamics.

Population Pharmacokinetic–Pharmacodynamic Modeling and Probability of Target Attainment Analysis of Rocuronium and Sugammadex in Children Undergoing Surgery

P. Wiczling, M. Książkiewicz, A. Bienert, 2022, European Journal of Drug Metabolism and Pharmacokinetics.

The influence of the time of day on midazolam pharmacokinetics and pharmacodynamics in rabbits

R. Kaliszan, P. Wiczling, H. Billert, 2014, Pharmacological reports : PR.

Melatonin and clonidine premedication has similar impact on the pharmacokinetics and pharmacodynamics of propofol target controlled‐infusions

K. Kusza, P. Wiczling, Z. Kokot, 2015, Journal of clinical pharmacology.

Potential pitfalls of propofol target controlled infusion delivery related to its pharmacokinetics and pharmacodynamics

Paweł Wiczling, K. Kusza, P. Wiczling, 2012, Pharmacological reports : PR.

Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery

R. Kaliszan, P. Wiczling, P. Sobczyński, 2012, Pharmacological reports : PR.

Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I–III patients

K. Kusza, P. Wiczling, A. Wolc, 2011, Arzneimittelforschung.

The pharmacokinetics of propofol in ICU patients undergoing long‐term sedation

P. Wiczling, Z. Kokot, J. Matysiak, 2016, Biopharmaceutics & drug disposition.

Pharmacokinetics and pharmacodynamics of propofol in children undergoing different types of surgeries

R. Kaliszan, P. Wiczling, Z. Kokot, 2014, Pharmacological reports : PR.

Population Modeling of Filgrastim PK‐PD in Healthy Adults Following Intravenous and Subcutaneous Administrations

Wojciech Krzyzanski, Etienne Pigeolet, Martin Fink, 2010, Journal of clinical pharmacology.

Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery

Paweł Wiczling, Damian Szczesny, Roman Kaliszan, 2015, Journal of Pharmacokinetics and Pharmacodynamics.

The influence of age and dosage on the pharmacodynamics of dexmedetomidine in rabbits

R. Kaliszan, P. Wiczling, H. Billert, 2014 .

Pharmacokinetics of dexmedetomidine during analgosedation in ICU patients

P. Wiczling, T. Małkiewicz, Z. Kokot, 2017, Journal of Pharmacokinetics and Pharmacodynamics.

Influence of Time of Day on Propofol Pharmacokinetics and Pharmacodynamics in Rabbits

P. Wiczling, Z. Kokot, J. Matysiak, 2011, Chronobiology international.

The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats

R. Kaliszan, P. Wiczling, W. Krzyzanski, 2014, Biopharmaceutics & drug disposition.

Flow cytometric analysis of reticulocyte maturation after erythropoietin administration in rats

S. Ait-Oudhia, P. Wiczling, W. Krzyzanski, 2009, Cytometry Part A.

Pharmacokinetics and Pharmacodynamics of a Chimeric/Humanized Anti‐CD3 Monoclonal Antibody, Otelixizumab (TRX4), in Subjects With Psoriasis and With Type 1 Diabetes Mellitus

W. Jusko, L. Vaickus, M. Rosenzweig, 2010, Journal of clinical pharmacology.

Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease

K. Neville, U. Garg, S. Abdel‐Rahman, 2014, Journal of clinical pharmacology.

Verification of the exponential model of body temperature decrease after death in pigs

R. Kaliszan, P. Wiczling, R. Hauser, 2005, Experimental physiology.

Population Pharmacokinetic Modelling of Filgrastim in Healthy Adults following Intravenous and Subcutaneous Administrations

Wojciech Krzyzanski, Etienne Pigeolet, Frank Lüdicke, 2009, Clinical pharmacokinetics.

Thermodynamic vs. extrathermodynamic modeling of chromatographic retention.

R. Kaliszan, M. Markuszewski, P. Wiczling, 2011, Journal of chromatography. A.

Flow cytometric assessment of homeostatic aging of reticulocytes in rats.

P. Wiczling, W. Krzyzanski, 2008, Experimental hematology.

Method of determination of the reticulocyte age distribution from flow cytometry count by a structured‐population model

P. Wiczling, W. Krzyzanski, 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats

M. Markuszewski, P. Wiczling, Damian Szczesny, 2020, Pharmacological Reports.

Retention time and peak width in the combined pH/organic modifier gradient high performance liquid chromatography.

R. Kaliszan, P. Wiczling, 2010, Journal of chromatography. A.

A new pH/organic modifier gradient RP HPLC method for convenient determination of lipophilicity and acidity of drugs as applied to established imidazoline agents.

R. Kaliszan, P. Wiczling, A. Nasal, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Reversed-phase TLC and HPLC retention data in correlation studies with in silico molecular descriptors and druglikeness properties of newly synthesized anticonvulsant succinimide derivatives.

R. Kaliszan, N. Milošević, P. Wiczling, 2011, Molecular pharmaceutics.

The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery

P. Wiczling, P. Sobczyński, A. Bienert, 2020, Journal of Pharmacokinetics and Pharmacodynamics.

Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery – a study of pharmacodynamic drug–drug interactions

Paweł Wiczling, Krzysztof Bieda, P. Wiczling, 2016, Biopharmaceutics & drug disposition.

Simultaneous determination of pKa and lipophilicity by gradient RP HPLC.

R. Kaliszan, P. Wiczling, Piotr Kawczak, 2006, Analytical chemistry.

pH Effects on Chromatographic Retention Modes

R. Kaliszan, P. Wiczling, Łukasz Kubik, 2015 .

The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients. A Bayesian approach with informative priors

R. Kaliszan, D. Siluk, P. Wiczling, 2016, Journal of Pharmacokinetics and Pharmacodynamics.

Application of Bayesian Multilevel Modeling in the Quantitative Structure-Retention Relationship Studies of Heterogeneous Compounds.

P. Wiczling, Łukasz Kubik, Agnieszka Kamedulska, 2021, Analytical chemistry.

Analysis of Isocratic-Chromatographic-Retention Data using Bayesian Multilevel Modeling.

R. Kaliszan, P. Wiczling, Łukasz Kubik, 2018, Analytical chemistry.

Statistical analysis of isocratic chromatographic data using Bayesian modeling

P. Wiczling, Łukasz Kubik, Agnieszka Kamedulska, 2022, Analytical and Bioanalytical Chemistry.

Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial

P. Wiczling, D. Onichimowski, M. Borys, 2020, Pharmacological Reports.

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19

P. Wiczling, M. Borys, P. Piwowarczyk, 2023, Clinical Pharmacokinetics.

Pharmacokinetics of sufentanil during long‐term infusion in critically ill pediatric patients

R. Kaliszan, D. Tibboel, P. Wiczling, 2016, Journal of clinical pharmacology.

QSAR, QSPR and QSRR in Terms of 3‐D‐MoRSE Descriptors for In Silico Screening of Clofibric Acid Analogues

R. Kaliszan, P. Wiczling, A. Ammazzalorso, 2012, Molecular informatics.

Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients

K. Kusza, P. Wiczling, Z. Kokot, 2010, Journal of Pharmacokinetics and Pharmacodynamics.

Targeted quantitative metabolomics with a linear mixed-effect model for analysis of urinary nucleosides and deoxynucleosides from bladder cancer patients before and after tumor resection

W. Struck-Lewicka, M. Markuszewski, D. Siluk, 2023, Analytical and Bioanalytical Chemistry.

Simultaneous determination of hydrophobicity and dissociation constant for a large set of compounds by gradient reverse phase high performance liquid chromatography-mass spectrometry technique.

R. Kaliszan, W. Struck-Lewicka, P. Wiczling, 2015, Journal of chromatography. A.

How Much Can We Learn from a Single Chromatographic Experiment? A Bayesian Perspective.

R. Kaliszan, P. Wiczling, 2016, Analytical chemistry.